What is "arformoterol"

n. A long-acting beta-adrenoceptor agonist drug (LABA) indicated for the treatment of chronic obstructive pulmonary disease.

Arformoterol is a long-acting β adrenoreceptor agonist (LABA) indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion, under the trade name Brovana, as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization.

It is the active (R,R)-- enantiomer of formoterol and was approved by the United States Food and Drug Administration (FDA) on October 6, 2006 for the treatment of COPD.